EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Shrinking lung syndrome with favourable response to belimumab and corticosteroids alone

Rémy Père, Anouk Le Goueff, Marina Nguenang

European Journal of Case Reports in Internal Medicine · 16.10.2026 · 13 (11)

DOI: 10.12890/2026_007315 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Case Reports in Internal Medicine, online erschienen am 16.10.2026. Verfasst von Rémy Père und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pneumology, Centre Hospitalier de Luxembourg, Luxembourg, Luxembourg. Die Arbeit nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Shrinking lung syndrome (SLS) is a rare complication of systemic lupus erythematosus. It is characterized by dyspnoea and a restrictive ventilatory defect, often associated with pleuritic chest pain. Given its rarity, there is no standardized treatment. Most published case reports describe a favourable outcome with corticosteroids alone or in combination with other immunosuppressive agents, such as cyclophosphamide or rituximab. Only a few cases treated with belimumab have been reported. Case description: We present the case of a 16-year-old female presenting with pleuritic chest pain, orthopnoea, and a restrictive ventilatory defect. Further investigations revealed positive antinuclear antibodies, a small left pleural effusion, and mild elevation of the left hemidiaphragm, findings consistent with SLS. Treatment with corticosteroids and belimumab was initiated, leading to significant clinical and biological improvement.

Conclusion

This case highlights the potential role of belimumab as a first-line treatment for SLS in combination with corticosteroids alone.

Schlagwörter

Stichwörter der Autor:innen

Shrinking lung syndromebelimumab

Autor:innen und Institutionen

  • Department of Pneumology, Centre Hospitalier de Luxembourg, Luxembourg, Luxembourg.
  • Department of Immuno-Allergology, Centre Hospitalier de Luxembourg, Luxembourg, Luxembourg.

Zitieren

APA

Père, R., Le Goueff, A., & Nguenang, M. (2026). Shrinking lung syndrome with favourable response to belimumab and corticosteroids alone. European Journal of Case Reports in Internal Medicine, 13(11). https://doi.org/10.12890/2026_007315

Vancouver

Père R, Le Goueff A, Nguenang M. Shrinking lung syndrome with favourable response to belimumab and corticosteroids alone. European Journal of Case Reports in Internal Medicine. 2026;13(11). doi:10.12890/2026_007315

BibTeX
@article{Pre2026,
  author = {Père, Rémy and Le Goueff, Anouk and Nguenang, Marina},
  title = {Shrinking lung syndrome with favourable response to belimumab and corticosteroids alone},
  journal = {European Journal of Case Reports in Internal Medicine},
  year = {2026},
  volume = {13},
  number = {11},
  doi = {10.12890/2026_007315}
}
Kostenlos starten →